The Fund is a non-diversified, closed-end investment company whose objective is to seek long-term capital appreciation primarily through investment in equity and equity-linked securities of Swiss companies.
The Fund is listed on the New York Stock Exchange under the symbol "SWZ".
Percentages based on the Fund's February 28, 2023 Total Net Assets.
Holding | Shares | % of Portfolio |
Nestle | 195,137 | 18.48% |
Roche Holding | 45,177 | 10.96% |
Novartis AG | 142,229 | 10.07% |
Richemont (CIE Fin) | 43,104 | 5.46% |
Zurich Insurance Group AG | 11,430 | 4.56% |
Partners Group HLG | 3,782 | 3.02% |
Lonza Group AG | 5,062 | 2.53% |
SIKA AG | 8,912 | 2.10% |
SWISS LIFE HLDG | 4,130 | 2.09% |
UBS GROUP AG | 113,876 | 2.08% |